ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "CMS Final Rule - Part 2"
Episode Synopsis
Matt Kerschner, Director of Regulatory Affairs and Policy at the American Academy of Neurology, continues his discussion on the CMS final rule. Show references: https://www.aan.com/advocacy/how-will-the-cms-fee-schedule-affect-you
More episodes of the podcast Neurology Minute
Levetiracetam - Part 2
12/01/2026
Multiple System Atrophy Without Dysautonomia
08/01/2026
Levetiracetam - Part 1
07/01/2026
In God we trust